UniProt ID | TRM6_HUMAN | |
---|---|---|
UniProt AC | Q9UJA5 | |
Protein Name | tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 | |
Gene Name | TRMT6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 497 | |
Subcellular Localization | Nucleus . | |
Protein Description | Substrate-binding subunit of tRNA (adenine-N(1)-)-methyltransferase, which catalyzes the formation of N(1)-methyladenine at position 58 (m1A58) in initiator methionyl-tRNA. [PubMed: 16043508 Together with the TRMT61A catalytic subunit, part of a mRNA N(1)-methyltransferase complex that mediates methylation of adenosine residues at the N(1) position of a small subset of mRNAs: N(1) methylation takes place in tRNA T-loop-like structures of mRNAs and is only present at low stoichiometries] | |
Protein Sequence | MEGSGEQPGPQPQHPGDHRIRDGDFVVLKREDVFKAVQVQRRKKVTFEKQWFYLDNVIGHSYGTAFEVTSGGSLQPKKKREEPTAETKEAGTDNRNIVDDGKSQKLTQDDIKALKDKGIKGEEIVQQLIENSTTFRDKTEFAQDKYIKKKKKKYEAIITVVKPSTRILSIMYYAREPGKINHMRYDTLAQMLTLGNIRAGNKMIVMETCAGLVLGAMMERMGGFGSIIQLYPGGGPVRAATACFGFPKSFLSGLYEFPLNKVDSLLHGTFSAKMLSSEPKDSALVEESNGTLEEKQASEQENEDSMAEAPESNHPEDQETMETISQDPEHKGPKERGSKKDYIQEKQRRQEEQRKRHLEAAALLSERNADGLIVASRFHPTPLLLSLLDFVAPSRPFVVYCQYKEPLLECYTKLRERGGVINLRLSETWLRNYQVLPDRSHPKLLMSGGGGYLLSGFTVAMDNLKADTSLKSNASTLESHETEEPAAKKRKCPESDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEGSGEQP -------CCCCCCCC | 13.69 | - | |
4 | Phosphorylation | ----MEGSGEQPGPQ ----CCCCCCCCCCC | 26.33 | 26714015 | |
29 | Ubiquitination | DGDFVVLKREDVFKA CCCEEEEEHHHHHHH | 41.97 | 24816145 | |
35 | Ubiquitination | LKREDVFKAVQVQRR EEHHHHHHHHHCCCC | 47.71 | 29967540 | |
87 | Phosphorylation | REEPTAETKEAGTDN CCCCCCCHHCCCCCC | 31.55 | - | |
88 | Ubiquitination | EEPTAETKEAGTDNR CCCCCCHHCCCCCCC | 36.75 | 21906983 | |
88 (in isoform 1) | Ubiquitination | - | 36.75 | 21890473 | |
88 (in isoform 2) | Ubiquitination | - | 36.75 | 21890473 | |
88 (in isoform 3) | Ubiquitination | - | 36.75 | 21890473 | |
91 | Ubiquitination | TAETKEAGTDNRNIV CCCHHCCCCCCCCCC | 34.39 | 21890473 | |
92 | Phosphorylation | AETKEAGTDNRNIVD CCHHCCCCCCCCCCC | 36.83 | - | |
102 | Acetylation | RNIVDDGKSQKLTQD CCCCCCCCCCCCCHH | 57.62 | 25953088 | |
103 | Ubiquitination | NIVDDGKSQKLTQDD CCCCCCCCCCCCHHH | 37.77 | - | |
103 | Ubiquitination | NIVDDGKSQKLTQDD CCCCCCCCCCCCHHH | 37.77 | 21890473 | |
103 | Phosphorylation | NIVDDGKSQKLTQDD CCCCCCCCCCCCHHH | 37.77 | - | |
105 | Ubiquitination | VDDGKSQKLTQDDIK CCCCCCCCCCHHHHH | 61.67 | 33845483 | |
107 | Phosphorylation | DGKSQKLTQDDIKAL CCCCCCCCHHHHHHH | 36.67 | 17525332 | |
112 | Ubiquitination | KLTQDDIKALKDKGI CCCHHHHHHHHHCCC | 55.45 | 21890473 | |
112 | Ubiquitination | KLTQDDIKALKDKGI CCCHHHHHHHHHCCC | 55.45 | 22817900 | |
112 (in isoform 2) | Ubiquitination | - | 55.45 | 21890473 | |
112 (in isoform 1) | Ubiquitination | - | 55.45 | 21890473 | |
112 (in isoform 3) | Ubiquitination | - | 55.45 | 21890473 | |
115 | Ubiquitination | QDDIKALKDKGIKGE HHHHHHHHHCCCCHH | 63.35 | 22817900 | |
117 | Ubiquitination | DIKALKDKGIKGEEI HHHHHHHCCCCHHHH | 62.03 | 22817900 | |
120 | Ubiquitination | ALKDKGIKGEEIVQQ HHHHCCCCHHHHHHH | 69.78 | 30230243 | |
138 | Ubiquitination | NSTTFRDKTEFAQDK CCCCCCCHHHHHHHH | 45.78 | 33845483 | |
145 | Methylation | KTEFAQDKYIKKKKK HHHHHHHHHHHHHHH | 36.47 | - | |
145 | Ubiquitination | KTEFAQDKYIKKKKK HHHHHHHHHHHHHHH | 36.47 | 29967540 | |
154 | Phosphorylation | IKKKKKKYEAIITVV HHHHHHCEEEEEEEE | 21.33 | 24719451 | |
158 | Ubiquitination | KKKYEAIITVVKPST HHCEEEEEEEECCCH | 2.85 | 24816145 | |
159 | Phosphorylation | KKYEAIITVVKPSTR HCEEEEEEEECCCHH | 17.09 | 24719451 | |
164 | Phosphorylation | IITVVKPSTRILSIM EEEEECCCHHHEEEE | 25.30 | 20068231 | |
165 | Phosphorylation | ITVVKPSTRILSIMY EEEECCCHHHEEEEE | 30.20 | 20068231 | |
169 | Phosphorylation | KPSTRILSIMYYARE CCCHHHEEEEECCCC | 11.70 | 20068231 | |
170 | Ubiquitination | PSTRILSIMYYAREP CCHHHEEEEECCCCC | 1.52 | 24816145 | |
172 | Phosphorylation | TRILSIMYYAREPGK HHHEEEEECCCCCCC | 7.72 | 20068231 | |
173 | Phosphorylation | RILSIMYYAREPGKI HHEEEEECCCCCCCC | 5.04 | 20068231 | |
176 | Ubiquitination | SIMYYAREPGKINHM EEEECCCCCCCCCCC | 50.67 | 29967540 | |
176 | Ubiquitination | SIMYYAREPGKINHM EEEECCCCCCCCCCC | 50.67 | - | |
185 | Phosphorylation | GKINHMRYDTLAQML CCCCCCCHHHHHHHH | 13.00 | 21406692 | |
187 | Phosphorylation | INHMRYDTLAQMLTL CCCCCHHHHHHHHHH | 18.30 | 21406692 | |
193 | Phosphorylation | DTLAQMLTLGNIRAG HHHHHHHHHCCCCCC | 27.55 | 21406692 | |
208 | Phosphorylation | NKMIVMETCAGLVLG CEEEEEEHHHHHHHH | 6.91 | 22210691 | |
226 | Phosphorylation | ERMGGFGSIIQLYPG HHCCCCCCEEEEECC | 17.79 | 25867546 | |
231 | Phosphorylation | FGSIIQLYPGGGPVR CCCEEEEECCCCCHH | 5.39 | 25867546 | |
273 (in isoform 1) | Ubiquitination | - | 38.89 | 21890473 | |
273 (in isoform 3) | Ubiquitination | - | 38.89 | 21890473 | |
273 | Ubiquitination | LHGTFSAKMLSSEPK HHCCCCCHHCCCCCC | 38.89 | 21890473 | |
273 (in isoform 2) | Ubiquitination | - | 38.89 | 21890473 | |
273 | Ubiquitination | LHGTFSAKMLSSEPK HHCCCCCHHCCCCCC | 38.89 | 22817900 | |
282 | Phosphorylation | LSSEPKDSALVEESN CCCCCCCCCCEECCC | 29.63 | 23663014 | |
288 | Phosphorylation | DSALVEESNGTLEEK CCCCEECCCCCHHHH | 27.36 | 23663014 | |
289 | Ubiquitination | SALVEESNGTLEEKQ CCCEECCCCCHHHHH | 51.23 | 22505724 | |
291 | Phosphorylation | LVEESNGTLEEKQAS CEECCCCCHHHHHHH | 34.93 | 23663014 | |
298 | Phosphorylation | TLEEKQASEQENEDS CHHHHHHHHHHCHHH | 37.00 | 30278072 | |
301 | Ubiquitination | EKQASEQENEDSMAE HHHHHHHHCHHHHHC | 59.54 | 32015554 | |
301 | Ubiquitination | EKQASEQENEDSMAE HHHHHHHHCHHHHHC | 59.54 | - | |
305 | Phosphorylation | SEQENEDSMAEAPES HHHHCHHHHHCCCCC | 17.45 | 10810093 | |
312 | Phosphorylation | SMAEAPESNHPEDQE HHHCCCCCCCCCCHH | 39.10 | 30576142 | |
320 | Phosphorylation | NHPEDQETMETISQD CCCCCHHHHHHHHCC | 18.06 | 29496963 | |
323 | Phosphorylation | EDQETMETISQDPEH CCHHHHHHHHCCCCC | 18.33 | 26074081 | |
325 | Phosphorylation | QETMETISQDPEHKG HHHHHHHHCCCCCCC | 35.63 | 26074081 | |
340 | Ubiquitination | PKERGSKKDYIQEKQ CCCCCCHHHHHHHHH | 58.42 | 24816145 | |
342 | Phosphorylation | ERGSKKDYIQEKQRR CCCCHHHHHHHHHHH | 17.24 | - | |
346 | Ubiquitination | KKDYIQEKQRRQEEQ HHHHHHHHHHHHHHH | 32.50 | 29967540 | |
417 | Methylation | CYTKLRERGGVINLR HHHHHHHCCCEEEEE | 40.51 | - | |
452 | Phosphorylation | LMSGGGGYLLSGFTV EEECCCCEECCCEEE | 14.03 | 23532336 | |
468 | Phosphorylation | MDNLKADTSLKSNAS ECCCCCCCCCCCCCH | 40.60 | 21712546 | |
469 | Phosphorylation | DNLKADTSLKSNAST CCCCCCCCCCCCCHH | 34.05 | 29214152 | |
471 | Ubiquitination | LKADTSLKSNASTLE CCCCCCCCCCCHHHH | 41.24 | 33845483 | |
472 | Phosphorylation | KADTSLKSNASTLES CCCCCCCCCCHHHHC | 42.81 | 24043423 | |
475 | Phosphorylation | TSLKSNASTLESHET CCCCCCCHHHHCCCC | 37.46 | 25159151 | |
476 | Phosphorylation | SLKSNASTLESHETE CCCCCCHHHHCCCCC | 31.94 | 25159151 | |
479 | Phosphorylation | SNASTLESHETEEPA CCCHHHHCCCCCCCH | 29.72 | 23312004 | |
482 | Phosphorylation | STLESHETEEPAAKK HHHHCCCCCCCHHHH | 39.98 | 23312004 | |
488 | Acetylation | ETEEPAAKKRKCPES CCCCCHHHHCCCCCC | 56.04 | 25953088 | |
495 | Phosphorylation | KKRKCPESDS----- HHCCCCCCCC----- | 28.44 | 24719451 | |
497 | Phosphorylation | RKCPESDS------- CCCCCCCC------- | 51.94 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRM6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRM6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRM6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VPS35_HUMAN | VPS35 | physical | 22939629 | |
VATB2_HUMAN | ATP6V1B2 | physical | 22939629 | |
SHOT1_HUMAN | KIAA1598 | physical | 22863883 | |
OGFR_HUMAN | OGFR | physical | 22863883 | |
DDX5_HUMAN | DDX5 | physical | 26344197 | |
DJC17_HUMAN | DNAJC17 | physical | 26344197 | |
EI2BA_HUMAN | EIF2B1 | physical | 26344197 | |
NH2L1_HUMAN | NHP2L1 | physical | 26344197 | |
TRUA_HUMAN | PUS1 | physical | 26344197 | |
RADI_HUMAN | RDX | physical | 26344197 | |
SNW1_HUMAN | SNW1 | physical | 26344197 | |
STK24_HUMAN | STK24 | physical | 26344197 | |
TLN2_HUMAN | TLN2 | physical | 26344197 | |
TTC4_HUMAN | TTC4 | physical | 26344197 | |
UT14A_HUMAN | UTP14A | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-107, AND MASSSPECTROMETRY. |